Genocea’s ATLAS Technology Shows Promise in Advancing Personalized Cancer Vaccines
News
ATLAS technology, by Genocea Biosciences, may be a useful tool to identify specific molecules in cancer patients that can help develop personalized vaccines, according to new research. These findings result ... Read more